Viewing Study NCT02207361


Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2026-01-21 @ 9:39 PM
Study NCT ID: NCT02207361
Status: UNKNOWN
Last Update Posted: 2015-12-22
First Post: 2014-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module